What do you know about participating in a research study?
The most comprehensive source of information about clinical studies is the database of clinical studies in the US found at clinicaltrials.gov. All new studies that are in search of participants are listed there, and the database can be searched by the state of one’s disease. However, the clinical trial listings on this site are complicated and difficult for the average person to understand. Here’s a quick guide to the terminology you might find in a clinical trial listing.
Phases of a clinical trial
These are the three stages of study for a new medication before it’s submitted to the FDA so that it can be approved for prescription.
Phase I studies are designed to study the safety of the medication.
Phase 2 studies are designed to test the medication’s efficacy.
Phase 3 studies are the final step, and have more participants to make sure the Phase 2 results are similar in a larger group of people with the condition or disease.
Types of study designs
In addition to a study’s phases, the study type can be described as:
Biomarker: Studies that are looking for risk factors, signs of disease, or severity of disease.
Natural history studies: These studies observe and determine how the symptoms of a disease can change or progress over time.
Interventional studies: Studies to assess new medications, devices, or non-medical therapies that can be used to treat a condition or symptoms of a condition.
Inclusion and exclusion criteria
Another important element in a clinical trials listing is the inclusion/exclusion criteria. The inclusion criteria refer to the qualities a person must have to be eligible to participate in a study. By reviewing these qualifications, you can tell if you are likely to be accepted as a participant. Here are some examples of the kinds of criteria a patient might need to meet to qualify for a study:
A specific diagnosis and diagnostic age
Age
Symptoms experienced
Current medications and treatment plans
Lab test results (e.g. blood test results; platelet levels (high or low); white blood cell levels; kidney and liver results)
Exclusion criteria are the factors that may prevent a patient from participating, such as:
Certain medications or a recent change in medication
Other conditions (such as heart disease, liver disease, etc.)
If pregnant or nursing
How the efficacy of a new potential medication is determined
Interventional studies, which test a new drug or treatment, must compare the potential new treatment to a pre-existing medication or treatment to determine if the new alternative really did make a difference and is better than what is currently available. In some studies, a comparison is made by giving an equal number of participants either the study drug or a placebo – which is a pill/injection/infusion that looks like the active treatment but does not contain an active drug ingredient. This way, the new potential treatment has to demonstrate a positive effect compared to the placebo. However, in many rare disease studies, placebos are not used alone without any treatment, but may be added to the existing usual treatment to see if the new drug has an increased beneficial effect.
The determination of which patients will receive the active drug or the placebo is randomized, like the toss of a coin. After the treatment period is over, in some studies you will find out whether you had the placebo or the active drug. You may be able to participate in an extension of the study, where every participant will receive the active study drug and be monitored while on it.
More resources are available about participating in a clinical trial:
Source:
The Basics: National Institute of Health. Clinical research trials and you. https://www.nih.gov/health-information/nih-clinical-research-trials-you/basics
Latest from Know Rare
Discover the latest treatments for IgA Nephropathy (IgAN), a rare kidney disease. Learn how current medications and emerging therapies work to slow progression, reduce proteinuria, and protect kidney function.
Discover how patient education empowers individuals with rare diseases to better understand their diagnosis, make informed decisions, and actively participate in their treatment plans. Learn why clear, compassionate communication is key to improving outcomes in rare disease care.
A heartfelt mother’s account on five years of navigating pediatric specialist waiting rooms with her medically complex child.
A powerful personal journey through Koolen-de Vries syndrome, ADHD, and neurodivergent parenting. Discover how one mother turned diagnosis into empowerment, embracing difference, healing guilt, and raising resilient, remarkable children in a world that doesn’t always understand.
Toni Roberts lives with Epidermolysis Bullosa, a rare genetic disorder that causes the skin to be extremely fragile and prone to blistering and tearing. Toni’s condition profoundly impacted her older sister, Cady Ward. Witnessing Toni’s daily struggles and challenges, Cady was inspired to become an advocate for rare disease and take on an extraordinary challenge—run an ultra-marathon.
Dr. David Fajgenbaum was in his third year of medical school when a rare and mysterious illness derailed his plans. Crushing fatigue, abdominal pain, and multiple swollen lymph nodes progressed rapidly, and he found himself in the ICU with multiple system organ failure. Recovering from the brink of death, he was diagnosed with Castleman disease (CD), a rare condition that at the time was thought to be a lymph node disease with similarities to cancer.
Learn about Dr. Rohit Aggarwal’s efforts in creating more centers of excellence for myositis, as well as educating, empowering, and connecting patients to clinical trials.
Recognizing the need for an effective way to treat becker muscular dystrophy, researchers have been studying the cause of muscle loss, and ways to stop it from happening.
After his diagnosis of limb-girdle muscular dystrophy type 2B at age 21, Chris initially opted for a safe career path, choosing jobs with steady income, benefits, and predictability. However, this decision made him feel like something was missing. Find out how Chris was finally able to follow his heart, finding purpose and contentment in becoming a writer.
Learn more about CureGRIN, founded in 2018 by parents of children diagnosed with GRIN Disorder to help find cures and therapies for people around the world suffering from these conditions.
Learn about the incredible story of Edward Gent, a Sports Nutritionist diagnosed with MMN, who decided to create an app to help others worldwide with their disease and symptom management.
Find out about 7 research areas identified as priorities in Sickle Cell Research and about a sickle cell disease drug, which was originally approved for treatment, that has been taken off the market.
It’s no secret that it is difficult to get to a pain medicine specialist. There are just so many people in pain who cannot find relief, and are looking for help. Learn about Bliss Health, which provides access to pain management services through virtual consultations, through a dedicated team of medical professionals who specialize in the diagnosis, treatment, and ongoing management of various types of chronic and acute pain conditions.
There are over 50 million people in the United States that live with chronic pain. However, researchers studying pain have learned something important: perception of pain is personal, and may have more to do with other factors than just the physical cause of the pain.
If you are coming across high copays and struggling to afford your treatment plan, here are a few options that may help you reduce the costs of your medications.
At age 15, Becca Salky became her own medical detective, playing a key role in uncovering her diagnosis. Now, as a Clinical Research Coordinator at Massachusetts General Hospital, she focuses on spreading awareness about MOG, finding better diagnostic tools, leading clinical trials, and fighting gender disparity.
On the “Rare Insights” podcast we bridge the gap between those living with rare diseases and the biopharmaceutical industry.
Why Men’s Health Week (June 10-16) matters for the Rare Community, and how you can take part.
June is Pride Month, and at Know Rare, we are committed to celebrating the rich diversity within the rare disease community.
Journalist Lindsay Guentzel describes navigating a diagnostic odyssey and how she manages day-to-day life with myositis in an impactful webinar.
When you live with a rare disease, the joyful experiences risks can bring are all the more valuable.
This summer, NMOSD and MOGAD patients, caregivers, clinicians, nurses, researchers, and advocates are invited to join The Sumaira Foundation at Emory for TSF's Atlanta Patient Day.
Know Rare writer Gina DeMillo Wagner’s new memoir, Forces of Nature explores powerful themes related to caregiving and rare disease.
Journalist Lindsay Guentzel offers an inside look at life with the rare muscular condition.
This May, Know Rare is shining a light on myositis, a group of rare autoimmune muscle diseases that can have profound effects on daily life. This is an important time for the myositis community and the rare disease community at large: a time to share stories from those living with the condition, share more information about the current state and future of the disease, and advocate for better treatments that will ultimately enhance the quality of life for those impacted by it. Whether you're a patient, caregiver, or advocate, join us in raising awareness and supporting those affected by myositis.
Author Chris Anselmo explains why being mindful of your pace can have major benefits for your health and well-being, and offers some tips to help.
